Aristotle Fund’s Oracle ORCL Stock Holding History

Aristotle Fund’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-97,000	Closed	-$4.27M	–	7
2018 Q2	$4.27M	Buy	+97,000	New	+$4.47M	4.32%	6

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Aristotle Fund's ORCL Position: Q3 2018 in Review

Aristotle Fund sold out of Oracle (ORCL) in Q3 2018, closing a stake of 97,000 shares — an estimated $4.27M sold.

Aristotle Fund first reported a position in ORCL in Q2 2018 and held it in 1 quarter. The position peaked at $4.27M in Q2 2018. 1,708 funds tracked by Wall St. Rank hold ORCL as of Q3 2018.

Aristotle Fund reported no remaining Oracle position as of Q3 2018 after selling out during the quarter.
Aristotle Fund sold 97,000 Oracle shares in Q3 2018, an estimated $4.27M.
Aristotle Fund first reported a position in Oracle in Q2 2018 and held it in 1 quarter.
Aristotle Fund's Oracle position peaked at $4.27M in Q2 2018.
1,708 funds tracked by Wall St. Rank held Oracle as of Q3 2018.

Based on Aristotle Fund's 13F filing for Q3 2018, filed 13 Nov 2018.